BIBLIOGRAPHY
- White GC, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev
J. Definitions in hemophilia: recommendation of the scientific
subcommittee on factor VIII and factor IX of the scientific and
standardization committee of the International Society on Thrombosis
and Haemostasis. Thromb Haemost. 2001;85(3):560.
- Van den Berg HM, De Groot PHG, Fischer K. Phenotypic heterogeneity in
severe hemophilia. J Thromb Hemost 2007; 5(s1): 151-156.
- Hoffman M. A cell-based model of coagulation and the role of factor
VIIa. Blood Rev 2003; 17(Suppl 1): S1–5.
- Walsh PN, Rainsford SG, Biggs R. Platelet coagulant activities and
clinical severity in haemophilia, Thromb. Diath. Haemorrh. 29 (1973)
722–729.
- Yee DL. Platelets as modifiers of clinical phenotype in hemophilia.
Scientific World Journal 6 (2006) 661–668.
- Riedl J, Ay C, Pabnger I. Platelets and hemophilia: A review of the
literature. Thrombosis Research 155 (2017) 131–139.
- McDaniel M. RN (2013). Treatment of Hemophilia A and B. Nursing
Working Group–Nurses’ Guide to Bleeding Disorders (chapter 6, pp
1-9). New York, National Hemophilia Foundation.
- Lacroix R, Judicone C, Mooberry M, et al. Standardization of
pre-analytical variables in plasma microparticle determination:
results of the International Society on Thrombosis and Haemostasis SSC
Collaborative workshop.J Thromb Haemost 2013;10.1111/jth.12207. doi:
10.1111/jth.12207.
- Fox SC, May J, Dovaltova N, Glenn JR, Johnson A, White AE, Ashwin
Radhakrishnan A, Heptinstall S. How does measurement of platelet
P-selectin compare with other methods of measuring platelet function
as a means of determining the effectiveness of antiplatelet therapy?.
Platelets 2019;30(3):290-295.
- Tesfamarian B. Distinct characteristics of neonatal platelet
reactivity. Pharmacol. Res 2017; 123:1-9. doi:
10.1016/j.phrs.2017.06.003
- Algathani M, Heptinstall S. Novel strategies for assessing platelet
reactivity. Future Cardiol. 2017; (1):33-47. doi:
10.2217/fca-2016-0054.
- van Bladel ER, Schutgens REG, Fischer K, de Groot PG, Roest M.
Platelet degranulation and glycoprotein IIbIIIa opening are not
related to bleeding phenotype in severe haemophilia A patients. Thromb
Haemost. 2014;111(6):1022–30.
- Podda GM, Bucciarelli P, Lussana F, Lecchi A, Cattaneo M. Usefulness
of PFA-100 testing in the diagnostic screening of patients with
suspected abnormalities of hemostasis: comparison with the bleeding
time. J Thromb Haemost. 2007;5(12):2393–8.
- Hayward CPM, Harrison P, Cattaneo M, Ortel TL, Rao AK. Platelet
function analyzer (PFA)-100 closure time in the evaluation of platelet
disorders and platelet function. J Thromb Haemost. 2006;4(2):312–9.
- Grünewald M, Siegemund A, Grünewald A, Konegen A, Koksch M,
Griesshammer M. Absence of compensatory platelet activation in
patients with severe haemophilia. but evidence for a platelet
collagen-activation defect. Platelets. 2002;13(8):451–8.
- Wartiovaara-Kautto U, Joutsi-Korhonen L, Ilveskero S, Armstrong E,
Lassila R. Platelets significantly modify procoagulant activities in
haemophilia A. Haemophilia. 2011;17(5):743–51.
- Favaloro EJ, Facey D, Henniker A. Use of a novel platelet function
analyzer (PFA-100) with high sensitivity to disturbances in von
Willebrand factor to screen for von Willebrand’s disease and other
disorders. Am J Hematol. 1999;62(3):165–74.
- Carcao MD, Blanchette VS, Dean JA, et al. The Platelet Function
Analyzer (PFA-100): a novel in-vitro system for evaluation of primary
haemostasis in children. Br J Haematol. 1998;101(1):70–3.
- Fressinaud E, Veyradier A, Truchaud F, et al. Screening for von
Willebrand disease with a new analyzer using high shear stress: a
study of 60 cases. Blood. 1998;91(4):1325–31.
- Haugaard AK, Lund TT, Birch C, et al. Discrepant coagulation profile
in HIV infection: elevated D-dimer but impaired platelet aggregation
and clot initiation. AIDS. 2013;27(17):2749–58.
- Writters P, Freson K, Verslype C, et al. Review article: blood
platelet number and function in chronic liver disease and cirrhosis.
Aliment Pharmacol Ther. 2008;27(11):1017–29.
- van Bladel ER, Roest M, de Groot PG, Schutgens REG. Up-regulation of
platelet activation in hemophilia A. Haematologica.
2011;96(6):888–95.
- Wartiovaara-Kautto U, Joutsi-Korhonen L, Ilveskero S, Armstrong E,
Lassila R. Platelets significantly modify procoagulant activities in
haemophilia A. Haemophilia. 2011;17(5):743–51.
- Teyssandier M, Delignat S, Rayes J, et al. Activation state of
platelets in experimental severe hemophilia A. Haematologica.
2012;97(7):1115–6.
- Ferreiro JL, Sibbing D, Angiolillo DJ. Platelet function testing and
risk of bleeding complications. Thromb Haemost. 2010;103(6):1128–35.
- Jennings LK, Dockter ME, Wall CD, Fox CF, Kennedy DM. Calcium
mobilization in human platelets using indo-1 and flow cytometry.
Blood. 1989;74(8):2674–80.
- Davies TA, Drotts D, Weil GJ, Simons ER. Flow cytometric measurements
of cytoplasmic calcium changes in human platelets. Cytometry.
1988;9(2):138–42.
- Owens AP, Mackman N. microvesicles in hemostasis and thrombosis. Circ
Res 2011; 108: 1284–97.
- Boulanger CM, Dignat-Georges FD. microvesicles: an introduction.
Arterioscler Thromb Vasc Biol 2011; 31: 2–3.
- Mobarrez F, Mikovic D, Antovic A, Antovic JP. Is a decrease of
microvesicles related to improvement of hemostasis after FVIII
injection in hemophilia A patients treated on demand? J Thromb
Haemost. 2013;11:697–703.
- Proulle V, Hugel B, Guillet B, et al. Circulating microvesicles are
elevated in haemophiliacs and non-haemophilic individuals aged
<18 years. Br J Haematol. 2005;131(4):487–9.
- Qin F, Huang S, Li Z, Ye J, Sun J. The Platelet-Derived microvesicles
Related to the Clinical Phenotype Heterogeneity of Hemophlia a. Blood.
2014;124(21):2828.
- Zhou X, Qin F, Li H, et al. Platelet-Derived microvesicles May
Influence Phenotypic Heterogeneity in Patients with Severe Hemophilia.
Blood. 2015;126(23):4673.
- Artoni A, Santagostino E, Mancuso ME, Lecchi A, Mannuci PM.
Microparticle levels are high in patients with Hemophilia A and can be
further increased by DDAVP administration. Blood. 2007;110(11):3139.
Figure 1. Calcium responses to ADP (A) or TRAP(B) of platelets as
measured with Fluo-3 by flow cytometry.
Figure 2. Area under the curve of the calcium responses shown in figure
1.
Figure 3. Platelet function by optical aggregation with PRP (with
Chronolog). AUC: area under the curve.
Figure 4. Platelet
function by whole blood impedance (with Multiplate). AUC: area under the
curve; U: units; UA; arbitrary units.
Figure 5. Platelet function evaluated by flow cytometry. FMI:
fluorescence mean intensity.